1. Home
  2. CRGX vs FF Comparison

CRGX vs FF Comparison

Compare CRGX & FF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • FF
  • Stock Information
  • Founded
  • CRGX 2021
  • FF N/A
  • Country
  • CRGX United States
  • FF United States
  • Employees
  • CRGX N/A
  • FF N/A
  • Industry
  • CRGX
  • FF Major Chemicals
  • Sector
  • CRGX
  • FF Industrials
  • Exchange
  • CRGX Nasdaq
  • FF Nasdaq
  • Market Cap
  • CRGX 180.4M
  • FF 172.1M
  • IPO Year
  • CRGX 2023
  • FF N/A
  • Fundamental
  • Price
  • CRGX $4.64
  • FF $3.94
  • Analyst Decision
  • CRGX Hold
  • FF Strong Buy
  • Analyst Count
  • CRGX 7
  • FF 1
  • Target Price
  • CRGX $4.67
  • FF $0.80
  • AVG Volume (30 Days)
  • CRGX 653.7K
  • FF 504.5K
  • Earning Date
  • CRGX 05-13-2025
  • FF 05-08-2025
  • Dividend Yield
  • CRGX N/A
  • FF 6.06%
  • EPS Growth
  • CRGX N/A
  • FF N/A
  • EPS
  • CRGX N/A
  • FF 0.35
  • Revenue
  • CRGX N/A
  • FF $243,339,000.00
  • Revenue This Year
  • CRGX $58.18
  • FF N/A
  • Revenue Next Year
  • CRGX N/A
  • FF N/A
  • P/E Ratio
  • CRGX N/A
  • FF $11.26
  • Revenue Growth
  • CRGX N/A
  • FF N/A
  • 52 Week Low
  • CRGX $3.00
  • FF $3.77
  • 52 Week High
  • CRGX $25.45
  • FF $6.40
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 59.08
  • FF 41.85
  • Support Level
  • CRGX $3.58
  • FF $3.86
  • Resistance Level
  • CRGX $4.17
  • FF $4.05
  • Average True Range (ATR)
  • CRGX 0.26
  • FF 0.22
  • MACD
  • CRGX 0.12
  • FF 0.01
  • Stochastic Oscillator
  • CRGX 92.98
  • FF 30.91

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About FF FutureFuel Corp. Common shares

FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.

Share on Social Networks: